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One pot reactionAbstract New optically active aminoalkylnaphthols were obtained by condensation of 2-naphthol,
substituted aromatic and heteroaromatic aldehydes and (R)-(+)-1-phenylethylamine or (S)-()-
1-phenylethylamine under conventional methods and ultrasonic irradiation. The enantiopure
aminoalkylnaphthol derivatives were converted in ring-closure reaction with formaldehyde to the
corresponding naphthoxazine derivatives.
ª 2014 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
The Mannich reaction is one of the most important carbon–
carbon bond forming reactions in organic synthesis (Kitamura
et al., 1995, 2004; Rijnberg et al., 1997; Kobayashi and Ishitani,
1999). The aminoalkylation of the electron rich aromatic
substrates by the Mannich Reaction affords synthetically and
biologically important compounds which are useful intermedi-
ates for the formation of various nitrogen-containing natural
products and pharmaceuticals (Tramontini and Angiolini,
1990, 1994; Mu¨ller et al., 1999; Chi et al., 1999; Pu and Yu,
2001; Turgut et al., 2007; Szatmari and Fu¨lo¨p, 2013). Betti
has prepared the aminoalkylnaphthols for the ﬁrst time atthe beginning of the 20th century (Betti 1941). The develop-
ment of novel stereoselective aminoalkylation of electron-rich
aromatic compounds ais recently of major interest. Particu-
larly new direct approaches that are stereoselective and mild
enough to permit the preparation of single diastereomers are
continuously attracting interest (Palmieri, 1999; Cimarelli
et al., 2001, 2002; Cimarelli and Palmieri, 2009; Cardellicchio
et al., 1999, 2010; Dong et al., 2004; Saidi et al., 2001, 2003;
Wei et al., 2011). Palmieri et al. and Wang et al. developed a
practical method for the stereoselective synthesis of amin-
oalkylnaphthols from 2-naphthol, aromatic aldehydes and
commercially available (R)-1-phenylethylamine. These com-
pounds exhibited fairly good enantioselectivities in the asym-
metric addition of diethylzinc to aromatic aldehydes
(Cimarelli et al., 2001; Liu et al., 2001).
Sonochemistry is the application of ultrasound to chemical
reactions and processes. Ultrasound irradiation, due to the
cavitational collapse, is able to activate many organic reac-
tions. In recent years, ultrasound irradiation has gained in-
creased attention as a clean and useful technique in organic
synthesis (Mason and Peters, 2003; Doble and Kumar, 2007;
Li et al., 2002). A broad range of the organic synthesis can
422 E. Pelit, Z. Turgutbe performed in higher yields, higher selectivities, shorter reac-
tion times and milder reaction conditions under ultrasonic
irradiation (Zeng et al., 2009; Chen and Li, 2009; Li et al.,
2011, 2005; Luche, 1998; Javanshir et al., 2011).
The development of new 1,3-oxazine derivatives has
attracted considerable attention due to their biological proper-
ties such as analgesic, anticonvulsant, antitubercular, antibac-
terial, antifungal and anticancer activities (Kurz, 2005; Zhao
et al., 2007; Tabuchi et al., 2009; Wang et al., 2008). Also in
recent years, these compounds are used in the treatment of
AIDS and Parkinson’s disease (Joyce et al., 2003; Kerdesky,
2005). Furthermore 1,3-oxazines are useful synthetic interme-
diates in organic synthesis.
Herein, we report on the preparation of aminoalkylnaph-
thols under conventional conditions and ultrasonic conditions
and the ring-closure reaction of these compounds.
2. Material and methods
2.1. General methods
1H and 13C NMR spectra were recorded on Varian-INOVA
and Mercury-VX spectrometers at 500 or 400 MHz and 125
or 100 MHz, respectively. Chemical shifts are given in ppm
downﬁeld from Me4Si in CDCl3 solution. Coupling constants
are given in Hz. The FTIR spectra were recorded on a Perkin-
Elmer FT-IR spectrometer (KBr). MS spectra were recorded
on Thermo Elemental X Series ICP-MS or VG 2AB-HFQ
double sector MS. The X-ray analysis was recorded on Rigaku
R-Axis Rapid-S X-ray Single Cristal Diffractometer. Optical
rotations were measured with Bellingham Stanley ADP-410
Polarimeter. Ultrasonication was performed in Intersonik clea-
ner with a frequency of 60 kHz and a power of 300 W. The
reaction ﬂasks were suspended at the centre of the bath, and
the addition or removal of water controlled the temperature
of the water bath. Melting points were measured on a Gallenk-
amp melting-point apparatus. Silica gel 60 (Merck) was used
for column separations. TLC was conducted on standard con-
version aluminium sheets pre-coated with a 0.2-mm layer of
silica gel. Elemental analyses were measured with Flash EA
1112 Series apparatus and were in good agreement (±0.2%)
with the calculated values. All reagents were commercially
available. THF was distilled and stored on sodium wire before
use. Commercial (R)-(+)-1-phenylethylamine and (S)-()-1-
phenylethylamine were used.
2.1.1. General procedure for the synthesis of aminoalkylnapthols
(1a–h and 2a–e)
A mixture of 2-naphthol (5.00 mmol), aromatic aldehyde
(6.00 mmol) and (R)-(+)-1-phenylethylamine or (S)-()-1-phen-
ylethylamine (5.25 mmol) was stirred at 60 C for 8–30 h under
nitrogen atmosphere. Aminoalkylnaphthols (1a–h and 2a–e)
were puriﬁed by column chromatography (hexane/EtOAc) di-
rectly from the reaction mixture, without any work-up.
2.1.2. General procedure for the synthesis of aminoalkylnapthols
under ultrasonic irradiation (1a–h and 2a–e)
For the ultrasound-assisted method a mixture of 2-naphthol
(5.00 mmol), aromatic aldehyde (6.00 mmol) and (R)-(+)-1-
phenylethylamine or (S)-()-1-phenylethylamine (5.25 mmol)was sonicated at 60 C under nitrogen atmosphere at the cen-
tre of an ultrasound cleaner bath for the period of time as indi-
cated in Tables 1 and 2. Aminoalkylnaphthols (1a–h and 2a–e)
were puriﬁed by column chromatography (hexane/EtOAc) di-
rectly from the reaction mixture, without any work-up.
2.1.3. 1-((R)-(4-bromophenyl)((R)-1-
phenylethylamino)methyl)naphthalen-2-ol 1a
White crystals, mp 131–133 C. ½a20D ¼ 185:6 (c 0.1, CHCl3).
FTIR vmax (KBr)/cm
1 3314, 3028, 2924, 2852, 1645, 1620,
1600, 1586, 1556, 1483, 1273, 1237, 1167, 1094, 1065, 830,
763, 701. 1H NMR dH (CDCl3, 500 MHz) 1.40 (d,
J= 6.74 Hz, 3H), 2.10 (br s, 1H), 3.78 (q, J= 6.74 Hz, 1H),
5.31 (s, 1H), 6.96 (br s, 1H), 7.06–7.31 (m, 13H), 13.43 (br s,
1H). 13C NMR dC (CDCl3, 125 MHz) 21.88, 55.62, 58.62,
111.59, 119.06, 119.80, 120.90, 121.50, 125.49, 125.60, 126.97,
127.83, 127.99, 128.42, 128.94, 131.15, 131.41, 139.50, 141.93,
156.21. MS m/z (ESI) 432 (M+), 311, 122. Anal. Calc. for C25-
H22BrNO (432.35): C 69.45, H 5.13, N 3.24. Found: C 69.58,
H 5.38, N 3.15%.
2.1.4. 1-((R)-(2,4-dimethylphenyl)((R)-1-
phenylethylamino)methyl)naphthalen-2-ol 1b
White crystals, mp 162–165 C. ½a20D ¼ 262:0 (c 0.1, CHCl3).
FTIR vmax (KBr)/cm
1 3445, 3313, 3060, 3027, 2970, 2896,
1619, 1582, 1517, 1497, 1468, 1272, 1238, 1154, 1092, 1076,
1035, 831, 815, 765, 702. 1H NMR dH (CDCl3, 400 MHz)
1.55(d, J= 6.80 Hz, 3H), 1.59 (br s, 1H), 1.93 (s, 3H), 2.21
(s, 3H), 3.91 (q, J= 6.80 Hz, 1H), 5.66 (s, 1H), 6.82 (br s,
1H), 6.92 (s, 1H), 7.15–7.39 (m, 10H), 7.74–7.77 (m, 2H),
13.79 (br s, 1H). 13C NMR dC (CDCl3, 100 MHz) 18.30,
21.10, 21.86, 56.86, 56.94, 114.24, 120.29, 121.13, 122.62,
126.74, 127.43, 127.46, 127.7, 128.29, 129.02, 129.05, 129.11,
129.80, 131.79, 132.86, 134.87, 136.25, 137.88, 142.93, 158.02.
MS m/z (ESI) 381 (M+), 274, 261, 143. Anal. Calc. for
C27H27NO (381.51): C 85.00, H 7.13, N 3.67. Found: C
84.65, H 7.11, N 3.97%.
2.1.5. 1-((S)-(2,4-dichlorophenyl)((R)-1-
phenylethylamino)methyl)naphthalen-2-ol 1c
White crystals, mp 150–152 C. ½a20D ¼ 259:7 (c 0.1, CHCl3).
FTIR vmax (KBr)/cm
1 3412, 3063, 3027, 2971, 2926, 1620,
1598, 1520, 1466, 1271, 1234, 1049, 815, 745, 699. 1H NMR
dH (CDCl3, 500 MHz) 1.51 (d, J= 6.83 Hz, 3H), 2.11 (br s,
1H), 3.93 (q, J= 6.83 Hz, 1H), 5.85 (s, 1H), 7.02 (br s, 1H),
7.16–7.32 (m, 11H), 7.73–7.78 (m, 2H), 13.44 (br s, 1H). 13C
NMR dC (CDCl3, 125 MHz) 20.66, 55.65, 56.19, 111.61,
118.96, 119.80, 121.76, 125.84, 126.29, 126.96, 127.04, 127.63,
127.83, 128.45, 129.24, 130.62, 131.33, 132.72, 133.57, 135.75,
141.04, 156.81. MS m/z (ESI) 422 (M+), 353, 300, 283, 266,
121. Anal. Calcd. for C25H21Cl2NO (422.35): C 71.10, H
5.01, N 3.32. Found: C 71.25, H 5.03, N 3.44%.
2.1.6. 1-((S)-(2,4-diﬂuorophenyl)((R)-1-
phenylethylamino)methyl)naphthalen-2-ol 1d
White crystals, mp 178–180 C. ½a20D ¼ 212:0 (c 0.1, CHCl3).
FTIR vmax (KBr)/cm
1 3354, 3017, 3002, 2968, 2864, 1621,
1600, 1555, 1519, 1466, 1270, 1220, 1159, 1142, 1100, 818,
745, 702. 1H NMR dH (CDCl3, 400 MHz) 1.53 (d,
J= 6.80 Hz, 3H), 2.30 (br s, 1H), 3.94 (q, J= 6.80 Hz, 1H),
Table 1 Synthesis of aminoalkylnaphthols and naphtoxazines in the presence of (R)-(+)-1-phenylethylamine.
Compound Ar Time, (h) Yield, (%)a drb Compound Time, (h) Yield, (%)a
(A) (B) (A) (B) (A) (B)
1a 8 3 74 78 60/40 55/45 3a 15 84
1b 12 4 67 70 66/34 62/38 3b 18 87
1c 12 4 66 70 74/26 70/30 3c 18 92
1d 15 4 69 71 68/32 64/36 3d 24 83
1e 18 5 62 65 65/35 60/40
1f 30 5 42 40 59/41 53/47
1g 18 5 41 43 72/28 70/30
1h 18 5 51 58 77/23 73/27
(A) stirring without ultrasound; and (B) under ultrasound irradiation.
a Yields of the pure isolated major diastereomer.
b The dr values were determined by 1H NMR of the reaction mixture.
Synthesis of enantiopure aminonaphthol derivatives with different techniques 4235.82 (s, 1H), 6.79 (br s, 1H), 7.12–7.46 (m, 10H), 7.68–7.81 (m,
2H), 13.51 (br s, 1H). 13C NMR dC (CDCl3, 100 MHz) 22.67,
52.60, 56.70, 103.80, 111.90, 119.90, 120.70, 122.70, 123.80,
123.90, 126.70, 126.80, 127.90, 128.70, 130.19, 131.26, 132.32,
142.37, 157.76, 158.90, 161.30, 163.80. MS m/z (ESI) 389
(M+), 269, 249, 122. Anal. Calc. for C25H21F2NO (389.44):
C 77.10, H 5.44, N 3.60. Found: C 76.90, H 5.50, N 3.80%.
2.1.7. 1-((R)-(3-ﬂuoro-4-methylphenyl)((i)-1-
phenylethylamino)methyl) naphthalen-2-ol 1e
White crystals, mp 111–113 C. ½a20D ¼ 180:0 (c 0.1, CHCl3).
FTIR vmax (KBr)/cm
1 3315, 3279, 3058, 3025, 2963, 1621,1600, 1582, 1467, 1413, 1269, 1237, 1158, 1115, 1077, 815,
756, 699. 1H NMR dH (CDCl3, 500 MHz) 1.51 (d,
J= 6.80 Hz, 3H), 2.17 (s, 3H), 2.24 (br s, 1H), 3.88 (q,
J= 6.80 Hz, 1H), 5.42 (s, 1H), 6.84–6.87 (m, 2H), 7.02–7.05
(m, 1H), 7.17–7.26 (m, 5H), 7.33–7.42 (m, 4H), 7.73–7.75 (m,
2H), 13.56 (br s, 1H). 13C NMR dC (CDCl3, 125 MHz)
13.15, 21.91, 55.62, 58.62, 111.78, 113.18, 119.09, 119.92,
121.43, 121.91, 123.62, 125.44, 125.63, 126.93, 127.80, 127.98,
128.85, 130.97, 131.52, 140.25, 142.01, 156.24, 159.47, 161.42.
MS m/z (ESI) 385 (M+), 265, 247. Anal. Calc. for C26H24FNO
(385.47): C 81.01, H 6.28, N 3.63. Found: C 80.90, H 6.40, N
3.40%.
Table 2 Synthesis of aminoalkylnaphthols and naphtoxazines in the presence of (S)-()-1-phenylethylamine.
Compound Ar Time, (h) Yield, (%)a drb Compound Time, (h) Yield, (%)a
(A) (B) (A) (B) (A) (B)
2a 8 3 73 77 58/42 53/47 4a 16 86
2b 14 5 65 68 63/37 60/40 4b 18 90
2c 14 5 68 72 72/28 67/33 4c 18 90
2d 16 5 72 74 63/37 59/41
2e 18 5 45 42 75/25 70/30
(A) stirring without ultrasound; and (B) under ultrasound irradiation.
a Yields of the pure isolated major diastereomer.
b The dr values were determined by 1H NMR of the reaction mixture.
424 E. Pelit, Z. Turgut2.1.8. 1-((R)-(5-bromo-2-hydroxyphenyl)
((R)-1-phenylethylamino)methyl)naphthalen-2-ol 1f
Yellow crystals, mp 129–130 C. ½a20D ¼ 143:4 (c 0.1, CHCl3).
FTIR vmax (KBr)/cm
1 3472, 3414, 3083, 3023, 2983, 2937,
1630, 1603, 1570, 1473, 1367, 1275, 1181, 1088, 820, 768,
700. 1H NMR dH (CDCl3, 500 MHz) 1.30 (br s, 1H), 1.62
(d, J= 6.35 Hz, 3H), 4.56 (q, J= 6.35 Hz, 1H), 5.20 (s,
1H), 6.85 (br s, 1H), 7.25–7.37 (m, 5H), 8.30 (br s, 1H),
13.54 (br s, 1H).13C NMR dC (CDCl3, 125 MHz) 23.64,
57.43, 67.36, 109.02, 118.02, 119.24, 125.42, 126.45, 127.79,
132.51, 133.92, 142.31, 159.23, 161.20. MS m/z (ESI) 448
(M+), 365, 327, 303, 255, 169. Anal. Calc. for C25H22BrNO2
(448.35): C 66.97, H 4.95, N 3.12. Found: C 65.85, H 5.05,
N 3.32%.
2.1.9. 1-((S)-(3-methylthiophen-2-yl)
((R)-1-phenylethylamino)methyl)naphthalen-2-ol 1g
White crystals, mp 153–155 C. ½a20D ¼ 274:0 (c 0.1, CHCl3).
FTIR vmax (KBr)/cm
1 3449, 3297, 3083, 3029, 2970, 2930,
1621, 1599, 1589, 1469, 1237, 1174, 1081, 1056, 823, 751,
703. 1H NMR dH (CDCl3, 400 MHz) 1.55 (d, J= 6.84 Hz,
3H), 1.89 (s, 3H), 2.17 (br s, 1H), 3.87 (q, J= 6.84 Hz, 1H),
5.75 (s, 1H), 6.70 (d, J= 5.09 Hz, 1H), 7.00(d, J= 5.09 Hz,
1H), 7.10–7.45 (m, 9H), 7.70–7.80 (m, 2H), 13.60 (br s, 1H).
13C NMR dC (CDCl3, 100 MHz) 13.23, 22.26, 52.89, 56.11,
114.12, 120.22, 120.64, 122.50, 124.43, 126.59, 126.96, 128.10,
128.62, 128.92, 129.63, 129.99, 132.43, 133.50, 139.06, 142.81,156.97. MS m/z (ESI) 373 (M+), 359, 343, 239. Anal. Calc.
for C25H23NOS (373.51): C 77.18, H 6.21, N 3.75. Found: C
76.85, H 6.45, N 3.95%.
2.1.10. 1-((S)-(4,5-dimethylfuran-2-yl)
((R)-1-phenylethylamino)methyl)naphthalen-2-ol 1h
White crystals, mp 145–147 C. ½a20D ¼ 128:0 (c 0.1, CHCl3).
FTIR vmax (KBr)/cm
1 3355, 3017, 3002, 2969, 2918, 1621,
1600, 1519, 1468, 1270, 1238, 1155, 1102, 1082, 1046, 834,
736, 703. 1H NMR dH (CDCl3, 400 MHz) 1.45(d,
J= 6.80 Hz, 3H), 1.90 (s, 3H), 2.20 (s, 3H), 2.50 (br s, 1H),
3.87 (q, J= 6.80 Hz, 1H), 5.50 (s, 1H), 7.00–7.80 (m, 12H),
13.10 (br s, 1H). 13C NMR dC (CDCl3, 100 MHz) 9.70,
11.45, 23.31, 53.29, 55.61, 111.16, 111.61, 114.89, 119.95,
121.09, 122.41, 126.44, 126.66, 127.70, 128.46, 128.65, 128.89,
129.85, 132.77, 142.87, 147.21, 150.06, 157.39. MS m/z (ESI)
371 (M+), 355, 266, 251. Anal. Calc. for C25H25NO2
(371.47): C 80.83, H 6.78, N 3.77. Found: C 80.50, H 6.58,
N 3.90%.
2.1.11. 1-((S)-(4-bromophenyl)((S)-1-
phenylethylamino)methyl)naphthalen-2-ol 2a
White crystals. mp 124–126 C. ½a20D ¼ þ100:8 (c 0.1, CHCl3).
FTIR vmax (KBr)/cm
1 3446, 3313, 3065, 3018, 2968, 1620,
1599, 1464, 1271, 1234, 1156, 1095, 846, 829, 752. 1H NMR
dH (CDCl3, 500 MHz) 1.50 (d, J= 6.60 Hz, 3H), 2.20 (br s,
1H), 3.90 (q, J= 6.60 Hz, 1H), 5.41 (s, 1H), 7.01–7.81 (m,
H3C NH2
Ph
Ar H
O
Method A CH2O
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1a-h 3a-d
or Method B
OH
OH
NHAr
PhH3C
O
NAr
PhH3C
Method A: stirring without ultrasound at 60 oC under N2 atmosphere
Method B: ultrasound irradiation at 60 oC under N2 atmosphere
Scheme 1 Synthesis of enantiopure aminoalkylnaphthols (1a–h) and naphthoxazines (3a–d).
Ph NH2
CH3
Ar H
O
CH2O
THF, r.t.
2a-e 4a-c
OH Method A
or Method B
OH
NHAr
PhH3C
O
NAr
PhH3C
Method A: stirring without ultrasound at 60 oC under N2 atmosphere
Method B: ultrasound irradiation at 60 oC under N2 atmosphere
Scheme 2 Synthesis of enantiopure aminoalkylnaphthols (2a–e) and naphtoxazines (4a–c).
Table 3 The reaction of 2-naphthol, 4-bromobenzaldehyde
and (R)-(+)-1-phenylethylaminea: effects of solvents (3 ml were
used).
Entry Solvent Time, (h) Temperature (C) Yield, (%)b
1 PhCH3 3 25 –
2 PhCH3 3 60 Trace
3 CH2Cl2 3 25 Trace
4 CH2Cl2 3 60 10
5 CH3CN 3 25 Trace
6 CH3CN 3 60 23
7 C2H5OH 3 25 17
8 C2H5OH 3 60 50
9 None 3 25 21
10 None 3 60 78
a Reactions were carried out under ultrasonic irradiation.
b Yields of the pure isolated major diastereomer.
Synthesis of enantiopure aminonaphthol derivatives with different techniques 42515H), 13.51 (br s, 1H). 13C NMR dC (CDCl3, 100 MHz) 22.95,
56.62, 59.62, 112.57, 120.08, 120.83, 121.94, 122.54, 126.53,
126.63, 128.02, 128.80, 129.03, 129.46, 129.98, 132.19, 132.40,
140.48, 142.92, 157.21. MS m/z (ESI) 432 (M+), 311, 232,
122. Anal. Calc. for C25H22BrNO (432.35): C 69.45, H 5.13,
N 3.24. Found: C 69.60, H 5.35, N 3.18%.
2.1.12. 1-((S)-(2,4-dimethylphenyl)
((S)-1-phenylethylamino)methyl)naphthalen-2-ol 2b
White crystals, mp 174–177 C. ½a20D ¼ þ257:8 (c 0.1, CHCl3).
FTIR vmax (KBr)/cm
1 3314, 3053, 3022, 2971, 1620, 1582,
1517, 1454, 1272, 1238, 1154, 1092, 1075, 831, 764, 702. 1H
NMR dH (CDCl3, 400 MHz) 1.52 (d, J= 6.80 Hz, 3H), 1.60
(br s, 1H), 1.90 (s, 3H), 2.25 (s, 3H), 3.90 (q, J= 6.80 Hz,
1H), 5.65 (s, 1H), 6.78–6.94 (m, 2H), 7.12–7.44 (m, 10H),
7.72–7.82 (m, 2H), 13.85 (br s, 1H). 13C NMR dC (CDCl3,
100 MHz) 18.07, 20.89, 21.62, 56.57, 56.66, 113.98, 120.04,
120.87, 122.40, 126.52, 127.20, 127.53, 128.07, 128.76, 128.82,
128.86, 129.57, 131.56, 132.60, 132.63, 134.64, 135.97, 137.66,
142.65, 157.76. MS m/z (ESI) 381 (M+), 216. Anal. Calc. for
C27H27NO (381.51): C 85.00, H 7.13, N 3.67. Found: C
84.75, H 7.15, N 3.94%.
2.1.13. 1-((R)-(2,4-dichlorophenyl)
((S)-1-phenylethylamino)methyl)naphthalen-2-ol 2c
White crystals, mp 145–147 C. ½a20D ¼ þ288:0 (c 0.1, CHCl3).
FTIR vmax (KBr)/cm
1 3311, 3058, 3022, 2980, 1629, 1580,
1469, 1 1273, 1181, 1089, 842, 767, 703. 1H NMR dH (CDCl3,
400 MHz) 1.52 (d, J= 6.80 Hz, 3H), 2.13 (br s, 1H), 3.95 (q,
J= 6.80 Hz, 1H), 5.86 (s, 1H), 7.01–7.35 (m, 12H), 7.75–
7.80 (m, 2H), 13.53 (br s, 1H). 13C NMR dC (CDCl3,
100 MHz) 21.93, 56.76, 57.33, 112.80, 120.20, 121.04, 123.04,
127.13, 127.57, 128.30, 128.89, 129.00, 129.10, 129.68, 130.51,131.86, 132.52, 133.95, 134.79, 136.88, 142.18, 158.01. MS m/
z (ESI) 422 (M+), 300, 266, 122. Anal. Calc. for C25H21Cl2NO
(422.35): C 71.10, H 5.01, N 3.32. Found: C 71.27, H 5.05, N
3.40%.
2.1.14. 1-((S)-(3-ﬂuoro-4-methylphenyl)
((S)-1-phenylethylamino)methyl)naphthalen-2-ol 2d
White crystals, mp 117–119 C. ½a20D ¼ þ160:0 (c 0.1, CHCl3).
FTIR vmax (KBr)/cm
1 3436, 3271, 3062, 2965, 1623, 1580,
1470, 1414, 1267, 1162, 1131, 1077, 817, 746, 702. 1H NMR
dH (CDCl3, 500 MHz) 1.41 (d, J= 6.80 Hz, 3H), 2.06 (s,
3H), 2.15 (br s, 1H), 3.78 (q, J= 6.80 Hz, 1H), 5.32 (s, 1H),
6.74–6.77 (m, 2H), 6.92–7.16 (m, 6H), 7.23–7.32 (m, 4H),
Figure 1 Molecular structure of compound 1b.
426 E. Pelit, Z. Turgut7.61–7.65 (m, 2H), 13.46 (br s, 1H). 13C NMR dC (CDCl3,
125 MHz) 13.14, 21.90, 55.61, 58.62, 111.77, 113.17, 119.08,
119.91, 121.90, 123.60, 125.44, 125.62, 126.93, 127.72, 127.79,
127.98, 128.85, 130.96, 131.51, 140.25, 141.99, 156.24, 159.46,
161.41. MS m/z (ESI) 385 (M+), 280, 265, 247, 122. Anal.
Calc. for C26H24FNO (385.47): C 81.01, H 6.28, N 3.63.
Found: C 80.92, H 6.43, N 3.45%.
2.1.15. 1-((R)-((S)-1-phenylethylamino)
(thiophen-2-yl)methyl)naphthalen-2-ol 2e
White crystals, mp 132–135 C. ½a20D ¼ þ140:0 (c 0.1, CHCl3).
FTIR vmax (KBr)/cm
1 3306, 3298, 3055, 3007, 2972, 1620,
1589, 1468, 1237, 1174, 1131, 1081, 823, 746, 701. 1H NMR
dH (CDCl3, 500 MHz) 1.52 (d, J= 6.63 Hz, 3H), 2.45 (br s,
1H), 3.88 (q, J= 6.63 Hz, 1H), 5.73 (s, 1H), 6.52–7.73 (m,
13H), 8.50 (br s, 1H), 13.35 (br s, 1H). 13C NMR dC (CDCl3,
125 MHz) 23.41, 54.94, 56.41, 113.85, 120.35, 121.10, 122.78,
125.35, 125.68, 126.83, 127.21, 128.19, 128.87, 129.07, 129.28,
130.26, 132.58, 143.00, 145.13, 157.00. MS m/z (ESI) 359
(M+), 343, 239. Anal. Calc. for C23H21NOS (359.48): C
76.85, H 5.89, N 3.90. Found: C 76.75, H 5.76, N 4.10%.
2.1.16. General procedure for the preparation of the
naphtoxazines (3a–d and 4a–c)
Aminonaphthols 1a–d and 2a–c (2 mmol) were dissolved in
THF (3 mL) and 35% aqueous formaldehyde (2.2 mmol)
was added. The solution was stirred for 15 h at room temper-
ature. Solvent was removed and the residue was dried underreduced pressure. The crude oil was puriﬁed by column chro-
matography eluting with EtOAc/hexane.
2.1.17. (R)-1-(4-bromophenyl)-2-((R)-1-phenylethyl)-
2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazine 3a
White crystals, mp 107–109 C. FTIR vmax (KBr)/cm1 3061,
3025, 2923, 2852, 1622, 1599, 1484, 1231, 1157, 1147, 10.71,
1010, 812, 745, 699. 1H NMR dH (CDCl3, 500 MHz) 1.43 (d,
J= 6.50 Hz, 3H), 3.86 (q, J= 6.50 Hz, 1H), 4.75 (d,
J= 9.5 Hz, 1H), 5.02 (d, J= 9.5 Hz, 2H), 5.06 (s, 1H) 6.79–
6.90 (m, 2H), 7.03–7.26 (m, 10H), 7.62–7.65 (m, 2H). 13C
NMR dC (CDCl3, 125 MHz) 20.44, 55.50, 58.05, 73.25,
110.49, 117.52, 120.20, 121.26, 122.21, 125.59, 126.56, 126.70,
127.54, 127.63, 127.94, 128.11, 129.80, 130.16, 131.68, 141.15,
144.13, 151.85. MS m/z (ESI) 444 (M+), 339, 133. Anal. Calc.
for C26H22BrNO (444.36): C 70.28, H 4.99, N 3.15. Found: C
69.10, H 5.21, N 3.53%.
2.1.18. (R)-1-(2,4-dimethylphenyl)-2-((R)-1-phenylethyl)-
2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazine 3b
White crystals, mp 121–123 C. FTIR vmax (KBr)/cm1 3062,
3026, 2970 2923, 1623, 1514, 1230, 1182, 1142, 1048, 898,
809, 743. 1H NMR dH (CDCl3, 500 MHz) 1.46 (d,
J= 6.36 Hz, 3H), 1.89 (s, 3H), 2.08 (s, 3H), 3.95 (q,
J= 6.36 Hz, 1H), 4.88 (dd, J1 = 10.74 Hz, J2 = 1.47 Hz,
1H), 4.98 (d, J= 10.74 Hz, 1H), 5.29 (s, 1H), 6.53–6.58 (m,
2H), 6.84–6.95 (m, 2H), 7.03–7.16 (m, 8H), 7.60–7.63 (m,
2H). 13C NMR dC (CDCl3, 125 MHz) 19.46, 20.15, 21.18,
Figure 2 Molecular structure of compound 2a.
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126.92, 127.90, 128.53, 128.87, 129.03, 129.43, 131.13, 131.97,
132.64, 137.05, 137.16, 137.95, 143.78, 153.11. MS m/z (ESI)
393 (M+), 288. Anal. Calc. for C28H27NO (393.52): C 85.46,
H 6.92, N 3.56. Found: C 85.30, H 6.80, N 3.75%.
2.1.19. (S)-1-(2,4-dichlorophenyl)-2-((R)-1-phenylethyl)-
2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazine 3c
White crystals, mp 118–119 C. FTIR vmax (KBr)/cm1 3061,
3029, 2970, 1622, 1584, 1467, 1231, 1149, 1140, 1015, 813,
744, 696. 1H NMR dH (CDCl3, 500 MHz) 1.44 (d,
J= 6.84 Hz, 3H), 4.32 (q, J= 6.84 Hz, 1H), 4.73 (dd,
J1 = 11.23 Hz, J2 = 1.4 Hz 1H), 4.76 (dd, J1 = 11.23 Hz,
J2 = 1.4 Hz 1H), 5.60 (s, 1H), 6.71–6.89 (m, 2H), 6.98–7.05
(m, 2H), 7.16–7.23 (m, 5H), 7.30–7.38 (m, 3H), 7.65–7.70 (m,
2H). 13C NMR dC (CDCl3, 125 MHz) 17.56, 54.27, 59.77,
72.85, 111.31, 117.62, 120.94, 122.33, 125.42, 125.87, 126.47,
127.10, 127.60, 128.13, 128.36, 128.98, 130.63, 131.34, 132.85,
133.88, 138.09, 141.55, 152.23. MS m/z (ESI) 434 (M+), 288.
Anal. Calc. for C26H21Cl2NO (434.36): C 71.89, H 4.87, N
3.22. Found: C 71.74, H 4.92, N 3.40%.
2.1.20. (S)-1-(2,4-ﬂuorophenyl)-2-((R)-1-phenylethyl)-
2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazine 3d
White crystals, mp 153–155 C. FTIR vmax (KBr)/cm1 3138,
3063, 2985, 1623, 1463, 1234, 1160, 1141, 1098, 1074, 841,
812, 744. 1H NMR dH (CDCl3, 500 MHz) 1.44 (d,
J= 6.90 Hz, 3H), 3.98 (q, J= 6.90 Hz, 1H,), 4.86 (d,
J= 11.00 Hz, 1H), 4.96 (d, J= 11.00 Hz, 1H), 5.40 (s, 1H),6.46–6.50 (m, 1H), 6.61–6.73 (m, 2H), 6.93–7.22 (m, 9H),
7.64–7.66 (m, 2H). 13C NMR dC (CDCl3, 125 MHz) 19.57,
50.72, 58.71, 73.21, 103.17, 109.37, 110.00, 117.48, 120.81,
122.25, 125.18, 125.26, 125.68, 126.41, 127.12, 127.60, 128.08,
128.23, 130.95, 131.35, 142.50, 152.11, 158.76, 162.40. MS m/
z (ESI) 401 (M+), 372, 297, 269, 133. Anal. Calc. for C26H21-
F2NO (401.45): C 77.79, H 5.27, N 3.49. Found: C 77.63, H
5.25, N 3.62%.
2.1.21. (S)-1-(4-bromophenyl)-2-((S)-1-phenylethyl)-
2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazine 4a
White crystals, mp 103–105 C. FTIR vmax (KBr)/cm1 3061,
3024, 2951, 1622, 1515, 1484, 1231, 1173, 1147, 1089, 1071,
812, 745, 699. 1H NMR dH (CDCl3, 500 MHz) 1.44 (d,
J= 6.50 Hz, 3H), 3.87 (q, J= 6.50 Hz, 1H), 4.76 (d,
J= 9.85 Hz, 1H), 5.03–5.04 (d, J= 9.85 Hz, 1H), 5.05 (s,
1H), 6.79–6.81 (m, 2H), 6.89–6.91 (m, 1H), 7.04–7.27 (m,
10H), 7.64–7.67 (m, 2H). 13C NMR dC (CDCl3, 125 MHz)
20.45, 55.51, 58.06, 73.26, 110.50, 117.53, 120.20, 121.27,
122.21, 125.60, 126.56, 126.71, 127.55, 127.64, 127.97, 128.12,
129.81, 130.17, 131.69, 141.16, 144.14, 151.86. MS m/z (ESI)
444 (M+), 339, 311, 133. Anal. Calc. for C26H22BrNO
(444.36): C 70.28, H 4.99, N 3.15. Found: C 69.92, H 5.21,
N 3.23%.
2.1.22. (S)-1-(2,4-dimethylphenyl)-2-((S)-1-phenylethyl)-
2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazine 4b
White crystals, mp 132–134 C. FTIR vmax (KBr)/cm1 3061,
3017, 2967, 1623, 1514, 1230, 1183, 1141, 1093, 1013, 897,
428 E. Pelit, Z. Turgut809, 743, 698. 1H NMR dH (CDCl3, 500 MHz) 1.49 (d,
J= 6.84 Hz, 3H), 1.91 (s, 3H), 2.12 (s, 3H), 3.97 (q,
J= 6.84 Hz, 1H), 4.90 (d, J= 10.73 Hz, 1H), 5.00 (d,
J= 10.73 Hz, 1H), 5.31 (s, 1H), 6.55–6.63 (m, 2H), 6.87–
7.07 (m, 3H), 7.10–7.28 (m, 8H), 7.37–7.40 (m, 1H), 7.64–
7.68 (m, 2H), 8.02–8.03 (m, 1H). 13C NMR dC (CDCl3,
125 MHz) 18.10, 18.79, 19.83, 53.90, 58.51, 73.21, 112.40,
117.28, 121.00, 122.00, 124.90, 126.55, 127.18, 127.51, 127.69,
129.17, 129.79, 129.79, 130.63, 131.29, 132.66, 135.72, 135.84,
136.60, 142.44, 151.76. MS m/z (ESI) 393 (M+), 288. Anal.
Calc. for C28H27NO (393.52): C 85.46, H 6.92, N 3.56. Found:
C 85.33, H 6.85, N 3.72%.
2.1.23. (R)-1-(2,4-dichlorophenyl)-2-((S)-1-phenylethyl)-
2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazine 4c
White crystals, mp 115–116 C. FTIR vmax (KBr)/cm1 3061,
3029, 2970, 1622, 1584, 1467, 1231, 1149, 1140, 1046, 1015,
899, 813, 744, 696. 1H NMR dH (CDCl3, 500 MHz) 1.39 (d,
J= 6.83 Hz, 3H), 4.29 (q, J= 6.83 Hz, 1H), 4.69 (dd,
J1 = 10 Hz, J2 = 1.50 Hz, 1H), 4.72 (d, J= 10 Hz, 1H),
5.57 (s, 1H), 6.65–6.79 (m, 2H), 6.96–7.01 (m, 2H), 7.11–7.17
(m, 5H), 7.26–7.33 (m, 3H), 7.59–7.63 (m, 2H). 13C NMR dC
(CDCl3, 125 MHz) 17.53, 54.24, 59.73, 72.79, 111.27, 117.60,
120.89, 122.30, 125.37, 125.84, 126.43, 127.06, 127.52, 128.09,
128.32, 128.92, 130.60, 131.29, 132.80, 133.84, 138.06, 141.51,
152.21. MS m/z (ESI) 434 (M+), 288. Anal. Calc. for C26H21-
Cl2NO (434.36): C 71.89, H 4.87, N 3.22. Found: C 71.77, H
4.95, N 3.37%. (See Schemes 1 and 2.)
3. Results and discussion
Electron-rich aromatic compounds such as 2-naphthol give
1-aminoalkylation with high yields when treated with (R)- or
(S)-1-phenylethylamine and aromatic or hetero-aromatic alde-
hydes in solvent-free conditions (Cimarelli et al., 2001, 2002;
Liu et al., 2001).
Diastereomerically pure aminoalkylnaphthols (1a–h and
2a–e) were prepared under conventional conditions according
to the literature method (Cimarelli et al., 2001) and under
ultrasound irradiation. The reactions proceeded smoothly with
aromatic or hetero-aromatic aldehydes nevertheless hetero-
aromatic aldehydes gave lower yields. The ring-closure reac-
tion of these aminoalkylnaphthols with formaldehyde gave
the 1,3-oxazine derivatives 3a–d and 4a–c. The reaction condi-
tions, yields and the structures of the aldehyde components are
summarised in Tables 1 and 2.
In order to demonstrate the effects of ultrasonic irradiation
in Mannich-type aminoalkylation reactions the synthesis of 1a
was investigated as a typical example at different temperatures
and in different solvents (Table 3). It was found that increasing
the temperature to 60 C has considerably improved the yield.
We also compared the efﬁciency of several organic solvents.
The reaction worked much better with the polar solvents than
the non-polar solvents. However the highest yields were ob-
tained under solvent-free conditions. As shown in Table 1
and Table 2, applying ultrasound irradiation signiﬁcantly re-
duced reaction times but did not bring about a noticeable
improvement in the stereoselectivities compared to the conven-
tional method. On the other hand, ultrasound irradiation has
provided better product yields.The structure of the newly generated compounds has been
clariﬁed by Fourier transform-infrared (FTIR), mass and
NMR techniques. Each of the aminoalkylnaphthol com-
pounds proved to be a pure single diastereoisomer by their
NMR spectra (a single peak near 5.20–5.90 ppm for their ben-
zyl proton in 1H NMR and one group peak in 13C NMR).
The characteristic absorption bands of OH and NH bands
were observed at 3280–3450 cm1 in the FTIR spectra of the
aminoalkylnaphthol derivatives. The H-atoms of CH3 were
observed in the ranges of 1.45–1.57 ppm. NH proton signals
were observed at 1.59–2.50 ppm; the H-atoms of CH, which
are near the CH3 group absorb in the ranges of 3.80–
4.50 ppm. The CH protons which are next to the Ar groups
were observed at 5.20–5.90 ppm, and the OH protons absorb
in the ranges of 13.10–13.80 ppm. The mass spectra of all
new compounds showed the expected molecular ion peak.
1H NMR and X-ray single-crystal studies were carried out
to determine the absolute conﬁguration of the newly generated
stereogenic centre at 1b and 2a. Fig. 1 clearly shows that the
conﬁguration of the newly generated centre is (R) for 1b and
Fig. 2 show that the conﬁguration of the newly generated cen-
tre is (S) for 2a. The X-ray study on these compounds also
shows a strong intramolecular hydrogen bond between OH
and N atom which gives rigidity to the molecules.
1,3-oxazine derivatives were prepared by the ring-closure
reactions of aminoalkylnaphthols 1a–d and 2a–c with formal-
dehyde in THF at room temperature. The structure of the new
1,3-oxazine compounds has been clariﬁed by Fourier trans-
form-infrared (FTIR), mass and NMR techniques.
The CH3 protons were observed at 1.40–1.47 ppm; CH pro-
tons which are next to CH3 group were observed at 3.80–
4.35 ppm; CH2 protons which are between N and O atoms ab-
sorb in the ranges of 4.70–5.00 ppm. The CH protons which
are near the Ar group were observed at 5.30–5.60 ppm.4. Conclusion
In summary, we synthesised new optically active aminoalkyl-
naphthol compounds in moderate to good yields by the reac-
tion of 2-naphthol with appropriate aldehydes and (R)- or
(S)-1-phenylethylamine under conventional conditions and
ultrasound irradiation. Compared with classical methods,
ultrasound irradiation procedure provided shorter reaction
times and higher yields. The ring-closure reactions of the amin-
oalkylnaphthols with formaldehyde gave 1,3-oxazine
derivatives.Acknowledgements
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